📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme. (2019)

First Author: Palace J

Attributed to: MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/jnnp-2018-318360

PubMed Identifier: 30242090

Publication URI: http://europepmc.org/abstract/MED/30242090

Type: Journal Article/Review

Volume: 90

Parent Publication: Journal of neurology, neurosurgery, and psychiatry

Issue: 3

ISSN: 0022-3050